Difference between revisions of "Ferrario CM, et al, Circulation (2005), cited as Ref 20 in DOI: 10.1007/s11886-020-01293-2 (Q11014)"
Jump to navigation
Jump to search
(Created claim: DOI Identifier (P138): 10.1161/CIRCULATIONAHA.104.510461, #quickstatements; #temporary_batch_1592836326594) |
(Created claim: Page(s) (P105): 2605-2610, #quickstatements; #temporary_batch_1592836326594) |
||
| (2 intermediate revisions by the same user not shown) | |||
| Property / PubMed ID | |||
| + | |||
| Property / PubMed ID: 15897343 / rank | |||
| + | Normal rank | ||
| Property / Volume | |||
| + | 111 | ||
| Property / Volume: 111 / rank | |||
| + | Normal rank | ||
| Property / Page(s) | |||
| + | 2605-2610 | ||
| Property / Page(s): 2605-2610 / rank | |||
| + | Normal rank | ||
Latest revision as of 14:32, 22 June 2020
Cited in: "Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty" Curr Cardiol Rep; 2020 04 29 ; 22 (5) 34.
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Ferrario CM, et al, Circulation (2005), cited as Ref 20 in DOI: 10.1007/s11886-020-01293-2
|
Cited in: "Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty" Curr Cardiol Rep; 2020 04 29 ; 22 (5) 34.
|
Statements
Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2 (English)
0 references
2005
0 references
Ferrario CM
0 references
Jessup J
0 references
Chappell MC
0 references
Averill DB
0 references
Brosnihan KB
0 references
Tallant EA
0 references
Diz DI
0 references
Gallagher PE
0 references
Circulation
0 references
111
0 references
2605-2610
0 references
